Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD

NCT07747571 | Not Yet Recruiting

• 1 other identifier: ACCEPT-TELEREHAB
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Pulmonary rehabilitation improves symptoms, exercise capacity, and quality of life in people with chronic obstructive pulmonary disease (COPD), but access and participation may be limited by travel, organizational, logistical, and personal barriers. Home-based pulmonary telerehabilitation may reduce some of these barriers, although not all eligible individuals accept this mode of care. Identifying the characteristics associated with acceptance or refusal of this model is therefore essential to better define the population most likely to benefit from this approach, tailor the program's delivery and content, and identify potential remaining barriers in order to improve access to care. This retrospective study will use existing data from adults with COPD who were screened at ADIR Association between May 2024 and April 2025 for an 8-week home-based pulmonary telerehabilitation feasibility study. Of 50 potentially eligible individuals, 21 accepted participation and 29 declined. Demographic, clinical, functional, psychological, and geographic characteristics will be compared between individuals who accepted and those who declined participation. Documented reasons for refusal will be described, and factors associated with refusal will be explored using logistic regression.

Conditions

Pulmonary Rehabilitation; Chronic Obstructive Pulmonary Disease (COPD)

Keywords

Telerehabilitation; Home-based pulmonary rehabilitation; Patient preference; Access to care

Outcome Measures

Primary Outcomes (1)

• Participation Decision Regarding Home-Based Pulmonary Telerehabilitation

  The participation decision recorded at screening will be classified as acceptance or refusal of the proposed 8-week home-based pulmonary telerehabilitation program. The number and percentage of participants in each category will be reported.

  At screening, before initiation of the proposed 8-week telerehabilitation program

Secondary Outcomes (25)

• Documented Reasons for Refusal of Home-Based Pulmonary Telerehabilitation

  At screening, when the participation decision was documented

• Distance From the Participant's Residence to the Pulmonary Rehabilitation Center

  At the time of screening

• Estimated Travel Time From the Participant Residence to the Pulmonary Rehabilitation Center

  At the time of screening

• Age At Screening

  At the time of screening

• Sex Distribution

  At the time of screening

Study Arms (2)

Group 1: Accepted Home-Based Pulmonary Telerehabilitation

Individuals who accepted participation in the original 8-week home-based pulmonary telerehabilitation feasibility study and were enrolled in that study. Expected source count: 21.

Other: No intervention

Group 2: Declined Home-Based Pulmonary Telerehabilitation

Individuals who were screened and considered potentially eligible for the original feasibility study but declined participation in the proposed home-based pulmonary telerehabilitation program. Expected source count: 29.

Other: No intervention

Interventions

No intervention OTHER

None for the present retrospective study.

Group 1: Accepted Home-Based Pulmonary Telerehabilitation; Group 2: Declined Home-Based Pulmonary Telerehabilitation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults with COPD who were screened at ADIR Association between May 2024 and April 2025 for an 8-week home-based pulmonary telerehabilitation feasibility study.

You may qualify if:

• Adults with COPD who were screened at ADIR Association between May 2024 and April 2025 for an 8-week home-based pulmonary telerehabilitation feasibility study. Please refer to ClinicalTrials.gov identifier NCT05314686.

You may not qualify if:

• Not applicable

Sponsors & Collaborators

• ADIR Association: lead
• University of Rouen Normandie: collaborator
• Hopital La Musse: collaborator

Study Sites (1)

ADIR Association

Rouen, Normandy, 76000, France

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Patient Preference

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Patient Satisfaction; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Tristan Bonnevie, PhD

  ADIR Association

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Tristan Bonnevie, PhD

CONTACT

+33235592970; t.bonnevie@adir-hautenormandie.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 31, 2026
• First Posted: August 5, 2026
• Study Start: September 1, 2026
• Primary Completion (Estimated): October 31, 2026
• Study Completion (Estimated): October 31, 2026
• Last Updated: August 10, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will share
• Time Frame: Data will be made available after publication.
• Access Criteria: Data will be made available upon request for research purposes. Requests should be sent to t.bonnevie@adir-hautenormandie.com

Locations

FR (1)